Articles On Cann Group (ASX:CAN)

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...

Each week, Stockhead recaps ASX stocks that are “running hot” as deduced by the Relative Strength Index (RSI). The RSI is a technical gauge which measures how trading momentum is affecting the price action. A reading of 70 is seen as the le...

The Community College of Denver (CCD) has just launched a cannabis business program in Colorado. The new program offers students the opportunity to earn an Associate of Applied Science degree designed to prepare them to become business mana...

Summary The S&P/ASX200 ended lower by just 10 basis points at 7,394.30, shedding early gains. The index gained 0.3% to hit an all-time high of 7,417.60 during the day’s trade. Material sector emerged as the best performer, settlin...

The stock is down 14.47% at time of writing, falling substantially as management revealed a decent quarterly result and plans for a fresh capital raise. The post Cann Group Shares Fall 14% as It Releases Quarterly Update appeared first on M...

Languishing pot stock Cann Group Ltd [ASX:CAN] is being punished by investors today. The CAN share price is down 14.47% at time of writing, falling substantially as management revealed a decent quarterly result and plans for a fresh capital...

The ASX clawed back initial gains to start the week, closing virtually flat today. The ASX 200 closed at 7,394 which was neck and neck with the point it closed at on Friday despite gaining as much as 0.3% in early trade. Meanwhile, the ASX...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small gain. At the time of writing, the benchmark index is up 0.1% to 7,400.7 points. Four ASX shares that have failed to follow the market higher today are...

Summary The benchmark index, S&P/ASX200, gained as much 0.3% to hit an all-time high of 7,417.60. BHP shares rose 1.8% to hit 52-week high on deal with Westshore Terminals Investment. Shares of Best & Less Group Holdings surge...

With construction of its state-of-the-art cultivation facility now underway in Mildura, medicinal cannabis company Cann Group (ASX: CAN) is rattling the tin again to bolster production capacity as market opportunities grow in Europe and Aus...

Summary The ASX 200 has continued its momentum in the opening session, making a record high. All three major US stock indices also closed at an all-time high on Friday after a volatile week. Metals X Limited is planning to recommence...

ASX 200 health stocks index rose by 0.68% this morning, compared to the broader index which rose by 0.24%. Respiratory device specialist, 4D Medical (ASX:4DX), led the pack, rising by 7%. In its quarterly update,  the company said it has ra...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

The Cann Group Ltd (ASX: CAN) share price is crashing lower on Monday morning. This follows the announcement of yet another capital raising by the cannabis company. At the time of writing, the Cann share price is down 14% to 32.5 cents. Wh...

Medical cannabis player is raising funds to support working capital needs and to strengthen its manufacturing capability.

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

The unfolding fraud drama involving Sydney-based lease financing company, Forum Finance, has caught some of  the world’s biggest banks by surprise. On July 2, Westpac Bank (ASX:WBC) blew the whistle on a potential fraud committed by its cli...

This week Technicorum Holdings announced an upcoming token sale and launch of The CanCoin – a cannabis token designed to solve market friction and monetisation in the European cannabis market and to help build blockchain-based solutions for...

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

The 2021 financial year was overall a very good one for ASX shares. The S&P/ASX 200 Index (ASX: XJO) managed to put on a performance of 24% for the 12 months to 30 June 2021. That makes FY2021 one of the best financial years ever for t...

Cannabis stocks have welcomed the change in ownership of Pershing Australia from Bank of New York Mellon (BNYM) to Finclear Pty Ltd which – effective immediately – will allow the trading of cannabis securities on the ASX. In late 2019, BNYM...

The Bod Australia Ltd (ASX: BDA) share price is a strong performer today following the release of a sales update. At the time of writing, shares in the CBD and hemp healthcare products company are up 3% to 35 cents. What’s driving the Bod...

The Althea Group Holdings Ltd (ASX: AGH) share price has been a positive performer on Wednesday. In early trade, the cannabis company’s shares are up 4.5% to 33.5 cents. Why is the Althea share price on a high today? Investors have been bu...

ShareCafeCann Group (ASX: CAN) – Hidden Gems Webinar Presenter – Shane Duncan – Chief Operating Officer – Cann Group’s vision is to provide access to a range of medicinal cannabis products for patients in Australia and globally.     Cann G...

ShareCafeHidden Gems Webinar Recap – Fresh Leaf Analytics, LGP, CAN, AGH & EMD Catch up on the full webinar with presentations from Fresh Leaf Analytics, Little Green Pharma (ASX: LGP), Cann Group (ASX: CAN) , Althea Group (ASX: AGH),...

The company’s current drug registration programs span its EMD-003 CBD medicine targeting mental health, EMD-004 for IBS and EMDMA-001 MDMA psychedelic-assisted therapy program targeting sufferers of treatment-resistant PTSD.

The US cannabis sector received a big lift after Amazon announced that job applicants at its offices and warehouses will no longer be drug-tested for marijuana use. Delivery drivers, however, will still be tested. The company also said it w...

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

There was plenty of action in the US regulatory front within the cannabis sector this week. A couple of major legislations during the week could potentially shake up the US cannabis industry. The Marijuana Opportunity Reinvestment and Expun...

The Cann Group Ltd (ASX: CAN) share price is falling during morning trade. This follows the cannabis company’s announcement of a revised revenue guidance for FY21. At the time of writing, Cann shares are exchanging hands for 43 cents, down...

In 2021, which of Europe and North America is the place to be for ASX cannabis stocks?   The case for Europe A few years ago there would’ve been no question that it was North America with Canada legalising recreational cannabis as well as h...

LBT Innovations (ASX:LBT) shares rose this morning after it sold its first two pathology sample analysers in the UK. LBT’s APAS Independence (Automated Plate Assessment System) sorts medical samples and uses AI and machine learning to deter...

A cannabis-based drug has been listed on Australia’s Pharmaceutical Benefits Scheme for the first time, as medical marijuana gains increased acceptance. The move means that an estimated 116 Aussies with a rare form of epilepsy known as Drav...

The outlook of the Horizons Marijuana Life Sciences Index ETF (HMMJ) reached a high for the week on Thursday, hitting 87.73% on the six-month performance chart before close of trading, after news broke that tobacco giant Philip Morris Inter...

The Cann Group Ltd (ASX: CAN) share price is holding its ground today despite announcing a product recall from one of its customers. During late afternoon trade, the cannabis company’s shares are fetching for 48.5 cents, up 1%. At one poin...

ASX pot stocks have run hot in recent months but eight in particular have been particularly rewarding for shareholders. Many pot stocks ran cold prior to COVID-19 as regulatory progress stalled and global markets didn’t take off. Australia...

April 20 has come and gone, but ASX cannabis companies aren’t getting that high — they’re actually low. Of the 36 pot companies in the space, 27 have lost ground over the last fortnight. Just seven have advanced. Gains were led by Wide Open...

Summary Emyria has received firm commitments in a well-supported placement to raise AU$5 million. The Company will use these funds to advance drug development and develop its product pipeline. The proceeds would also support the initi...

The number of medical cannabis prescriptions issued under Australia’s special access scheme just keeps on growing. There were a record 9,959 SAS Category B marijuana prescriptions issued in March, two and a half times the number from a year...

The S&P/ASX 200 Index (ASX: JXO) is having a pretty decent day today. A the time of writing, the ASX 200 is up a healthy pre-Easter 0.21%. But one group that is doing a quarter-ounce better are ASX cannabis shares. Take Creso Pharma Lt...

Australia’s medical marijuana industry is showing strong growth, according to an industry-leading biannual report. The Freshleaf Analytics report, released this morning, says that patient numbers have grown 15-fold over the past two and a h...

Emyria (ASX:EMD) and Cann Group (ASX:CAN) have announced a collaboration agreement under which they will seek accelerated registration of a low-dose cannabidiol (CBD) only capsule with the TGA.

The Cann Group Ltd (ASX: CAN) share price was out of form on Monday. The cannabis company’s shares fell 3.5% to 55 cents. This latest decline means the Cann share price is now down a disappointing 56% from its 52-week high. Why is the Cann...

Cann Group Ltd (ASX: CAN) shares opened slightly higher on Monday but have since retreated. This comes after the company announced a partnership with Emyria Ltd (ASX: EMD). At the time of writing, the Cann share price is trading 1.75% lowe...

Source:ShutterstockProfessional, Shutterstock Summary Althea Group Holdings Limited updated the market with a new and innovative range of its oil-based cannabis products. Cann Group and Emyria have entered in collaboration to accelera...

Cannabis companies Cann Group (ASX:CAN) and Emryia (ASX:EMD) are joining forces in a bid to be the first companies to have a low-dose cannabinoid (CBD) product approved for sale in Australian pharmacies without a prescription. They are hopi...

Source:ElRoi, Shutterstock Summary Cann Group is a $163.9 billion cannabis company focused on breeding, cultivating, manufacturing and supplying medicinal cannabis. AusCann Group is the smallest cannabis player in this list, with a ma...

If you’re travelling from Canada, Holland, certain US states, or any other parts of the world where recreational cannabis use has been legalised, step carefully if you plan to visit Japan. Japanese courts continue to enforce strict laws su...

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

Pot legalisation is creeping across the US state by state, and a major market could be about to join their ranks. Reports out of New York indicate that lawmakers in the Empire State are close to signing a new bill legalising recreational ca...